Indivior appeal fails to stop generic opioid addiction challenge
15-07-2019
IgorGolovniov / Shutterstock.com
The US Court of Appeals for the Federal Circuit has affirmed a US Patent Trial and Appeal Board (PTAB) decision that held that claims of a patent for dissolvable films containing therapeutic agents were anticipated.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Indiviior, Federal Circuit, Films, Dr Reddy, Patent, Patent Trial and Appeal Board
